Literature DB >> 33787023

COVID 19 infection in young patient with pectus excavatum

Luis René Puglla Sánchez1, Cristian Andrés Sinche Cueva2, Nasthia Coraly Quilismal Guanochanga3.   

Abstract

Introduction: The SARS-Cov-2 infection causing the COVID 19 disease mainly affects the respiratory system, in most cases presenting mild symptoms, however in patients with comorbidities such as pectus excavatum that cause an alteration in lung function, the disease It can be deadly. Case presentation: A 25-year-old male with a history of congenital pectus excavatum and scoliosis, with clinical of COVID 19 and confirmatory results of PCR, TC and Rx of the infection, begins with mild symptoms of affection in the upper respiratory tract, cough and odynophagia, that due to its basic anatomical alteration, progresses to SDRA, is treated with Oxygen Therapy, Ampicillin Sulbactam, Azithromycin, Oseltamivir, Lopinavir / Ritonavir, Hydroxychloroquine, Tiotropium, Paracetamol, Heparin and Omeprazole presenting a favorable evolution on the third day of hospitalization.
Conclusion: The case reflects what is known to date about the risk of severe complications that SARS-CoV-2 infection can present in patients with comorbidities or pathologies that alter lung function such as the pectus excavatum. Therefore it would be important to generate specific management protocols for the clinical improvement of these patients with congenital anatomical alterations. Universidad Nacional de Córdoba

Entities:  

Keywords:  COVID-19; pectus excavatum; respiratory distress; viral pneumonia

Mesh:

Year:  2021        PMID: 33787023      PMCID: PMC8713364          DOI: 10.31053/1853.0605.v78.n1.30308

Source DB:  PubMed          Journal:  Rev Fac Cien Med Univ Nac Cordoba        ISSN: 0014-6722


  8 in total

1.  Diminished pulmonary function in pectus excavatum: from denying the problem to finding the mechanism.

Authors:  Robert E Kelly; Robert J Obermeyer; Donald Nuss
Journal:  Ann Cardiothorac Surg       Date:  2016-09

2.  Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China.

Authors:  Minggui Lin; Lai Wei; Lixin Xie; Guangfa Zhu; Charles S Dela Cruz; Lokesh Sharma
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

3.  Defining the Epidemiology of Covid-19 - Studies Needed.

Authors:  Marc Lipsitch; David L Swerdlow; Lyn Finelli
Journal:  N Engl J Med       Date:  2020-02-19       Impact factor: 91.245

4.  Cutaneous manifestations in COVID-19: a first perspective.

Authors:  S Recalcati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

5.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

6.  COVID-19 and the cardiovascular system.

Authors:  Ying-Ying Zheng; Yi-Tong Ma; Jin-Ying Zhang; Xiang Xie
Journal:  Nat Rev Cardiol       Date:  2020-05       Impact factor: 32.419

Review 7.  COVID-19 pathophysiology: A review.

Authors:  Koichi Yuki; Miho Fujiogi; Sophia Koutsogiannaki
Journal:  Clin Immunol       Date:  2020-04-20       Impact factor: 3.969

8.  Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients.

Authors:  Suxin Wan; Qingjie Yi; Shibing Fan; Jinglong Lv; Xianxiang Zhang; Lian Guo; Chunhui Lang; Qing Xiao; Kaihu Xiao; Zhengjun Yi; Mao Qiang; Jianglin Xiang; Bangshuo Zhang; Yongping Chen; Cailiang Gao
Journal:  Br J Haematol       Date:  2020-04-20       Impact factor: 6.998

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.